Medicamen Biotech consolidated net profit declines 36.89% in the December 2025 quarter
(14 Feb 2026)

Back
Net profit of Medicamen Biotech declined 36.89% to Rs 2.19 crore in the quarter ended December 2025 as against Rs 3.47 crore during the previous quarter ended December 2024. Sales rose 3.92% to Rs 46.91 crore in the quarter ended December 2025 as against Rs 45.14 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales46.9145.14 4
OPM %9.3414.86 -
PBDT3.946.09 -35
PBT2.113.88 -46
NP2.193.47 -37

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew